GlassScriptPhysician profile
Kristin K Titko
NPI 1174515068
$656.41
in general payments reported to CMS, 2019-2025
15 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $15.67 · 2021: $25.77 · 2022: $48.51 · 2023: $66.84 · 2024: $61.90 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $183.92 | 2025 | Prodigy Catheter |
| Stryker Corporation | $146.56 | 2019 | |
| Sanara Medtech INC. | $47.76 | 2025 | Celleraterx |
| Treace Medical Concepts, INC. | $40.68 | 2024 | |
| Boston Scientific Corporation | $31.64 | 2019 | |
| Amgen INC. | $27.84 | 2025 | Krystexxa |
| Linvatec Corporation | $27.16 | 2023 | Fracture and Correction Colag 2 |
| Averitas Pharma INC. | $26.85 | 2023 | Qutenza |
| Organogenesis INC. | $25.77 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $21.59 | 2022 | |
| Nevro Corp. | $21.22 | 2024 | Senza |
| Bioventus LLC | $15.67 | 2020 | |
| Paratek Pharmaceuticals, INC. | $14.17 | 2022 | |
| Smith+Nephew, INC. | $12.83 | 2023 | Grafix Pl |
| Cordis US Corp. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Titko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.